The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 8,985 followers.

Toda medida que permita controlar parámetros metabólicos (encabezados por hiperglucemia y resistencia a la insulina) tendrá, por tanto, efectos antitumorales más o menos acusados. https://t.co/rxgOik9VgG https://t.co/pN51pZkSWj

30 Apr 2024

Reply Repost Favourite

New article: The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus https://t.co/bbuvehr3zF #lungcancer #oncology https://t.co/Hwn1h5LGmL

06 Dec 2021

Reply Repost Favourite

New research: The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus: Background Diabetes mellitus (DM) is a frequent comorbidity in patients with cancer. This study… https://t.c

16 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.